TXMD — TherapeuticsMD Cashflow Statement
0.000.00%
Last trade - 00:00
- $22.95m
- $18.62m
- $1.30m
- 14
- 32
- 38
- 18
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -176 | -184 | -172 | 112 | -10.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 23.8 | 26.3 | 24.4 | -113 | -21.3 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14 | -3.32 | 4.59 | -4.09 | -17.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -166 | -159 | -143 | -4.08 | -48.1 |
Capital Expenditures | -23.9 | -1.6 | -2.22 | -0.355 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.02 | — | 0 | 224 | 0 |
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -23.9 | -1.6 | -2.22 | 223 | 0 |
Financing Cash Flow Items | -6.65 | -1.25 | -5.12 | -1.27 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 189 | 80.7 | 130 | -235 | 3.15 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.783 | -80.3 | -15.4 | -15.8 | -45 |